Immediate Impact
1 from Science/Nature 47 hit
Citing Papers
The current state of the art and future trends in RAS-targeted cancer therapies
2022 Hit
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
2022 Hit
Works of Wendy De Roock being referenced
KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
2010
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
2010 Hit